☰

William L. Ince, Ph.D. - Publications

Affiliations: 
2010 Genetics & Molecular Biology University of North Carolina, Chapel Hill, Chapel Hill, NC 
Area:
Microbiology Biology, Virology Biology
Tree Info Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Hickerson BT, Petrovskaya SN, Dickensheets H, Donnelly RP, Ince WL, Ilyushina NA. Impact of Baloxavir Resistance-Associated Substitutions on Influenza Virus Growth and Drug Susceptibility. Journal of Virology. 97: e0015423. PMID 37404185 DOI: 10.1128/jvi.00154-23  0.325
2018 Kosik I, Ince WL, Gentles LE, Oler AJ, Kosikova M, Angel M, Magadán JG, Xie H, Brooke CB, Yewdell JW. Correction: Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs. Plos Pathogens. 14: e1007141. PMID 29924863 DOI: 10.1371/Journal.Ppat.1007141  0.328
2018 Kosik I, Ince WL, Gentles LE, Oler AJ, Kosikova M, Angel M, Magadán JG, Xie H, Brooke CB, Yewdell JW. Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs. Plos Pathogens. 14: e1006796. PMID 29346435 DOI: 10.1371/Journal.Ppat.1006796  0.416
2015 Frank GM, Angeletti D, Ince WL, Gibbs JS, Khurana S, Wheatley AK, Max EE, McDermott AB, Golding H, Stevens J, Bennink JR, Yewdell JW. A Simple Flow-Cytometric Method Measuring B Cell Surface Immunoglobulin Avidity Enables Characterization of Affinity Maturation to Influenza A Virus. Mbio. 6: e01156. PMID 26242629 DOI: 10.1128/Mbio.01156-15  0.356
2014 Brooke CB, Ince WL, Wei J, Bennink JR, Yewdell JW. Influenza A virus nucleoprotein selectively decreases neuraminidase gene-segment packaging while enhancing viral fitness and transmissibility. Proceedings of the National Academy of Sciences of the United States of America. 111: 16854-9. PMID 25385602 DOI: 10.1073/Pnas.1415396111  0.369
2014 Magadán JG, Altman MO, Ince WL, Hickman HD, Stevens J, Chevalier A, Baker D, Wilson PC, Ahmed R, Bennink JR, Yewdell JW. Biogenesis of influenza a virus hemagglutinin cross-protective stem epitopes. Plos Pathogens. 10: e1004204. PMID 24945804 DOI: 10.1371/Journal.Ppat.1004204  0.338
2013 Yewdell JW, Ince WL. Greasing the SCIDs for universal flu antibodies. Cell Host & Microbe. 14: 7-8. PMID 23870308 DOI: 10.1016/J.Chom.2013.07.002  0.365
2013 Das SR, Hensley SE, Ince WL, Brooke CB, Subba A, Delboy MG, Russ G, Gibbs JS, Bennink JR, Yewdell JW. Defining influenza A virus hemagglutinin antigenic drift by sequential monoclonal antibody selection. Cell Host & Microbe. 13: 314-23. PMID 23498956 DOI: 10.1016/J.Chom.2013.02.008  0.358
2013 Ince WL, Gueye-Mbaye A, Bennink JR, Yewdell JW. Reassortment complements spontaneous mutation in influenza A virus NP and M1 genes to accelerate adaptation to a new host. Journal of Virology. 87: 4330-8. PMID 23365443 DOI: 10.1128/Jvi.02749-12  0.376
2013 Brooke CB, Ince WL, Wrammert J, Ahmed R, Wilson PC, Bennink JR, Yewdell JW. Most influenza a virions fail to express at least one essential viral protein. Journal of Virology. 87: 3155-62. PMID 23283949 DOI: 10.1128/Jvi.02284-12  0.413
2012 Yewdell JW, Ince WL. Virology. Frameshifting to PA-X influenza. Science (New York, N.Y.). 337: 164-5. PMID 22798590 DOI: 10.1126/Science.1225539  0.401
2011 Das SR, Hensley SE, David A, Schmidt L, Gibbs JS, Puigbò P, Ince WL, Bennink JR, Yewdell JW. Fitness costs limit influenza A virus hemagglutinin glycosylation as an immune evasion strategy. Proceedings of the National Academy of Sciences of the United States of America. 108: E1417-22. PMID 22106257 DOI: 10.1073/Pnas.1108754108  0.374
2011 Anderson JA, Archin NM, Ince W, Parker D, Wiegand A, Coffin JM, Kuruc J, Eron J, Swanstrom R, Margolis DM. Clonal sequences recovered from plasma from patients with residual HIV-1 viremia and on intensified antiretroviral therapy are identical to replicating viral RNAs recovered from circulating resting CD4+ T cells. Journal of Virology. 85: 5220-3. PMID 21367910 DOI: 10.1128/Jvi.00284-11  0.636
2010 Ince WL, Zhang L, Jiang Q, Arrildt K, Su L, Swanstrom R. Evolution of the HIV-1 env gene in the Rag2-/- gammaC-/- humanized mouse model. Journal of Virology. 84: 2740-52. PMID 20042504 DOI: 10.1128/Jvi.02180-09  0.635
2009 Choudhary SK, Rezk NL, Ince WL, Cheema M, Zhang L, Su L, Swanstrom R, Kashuba AD, Margolis DM. Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gamma}c-/- mouse. Journal of Virology. 83: 8254-8. PMID 19494021 DOI: 10.1128/Jvi.00580-09  0.649
2009 Ince WL, Harrington PR, Schnell GL, Patel-Chhabra M, Burch CL, Menezes P, Price RW, Eron JJ, Swanstrom RI. Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization. Journal of Virology. 83: 4068-80. PMID 19211740 DOI: 10.1128/Jvi.02486-08  0.63
2008 Schnell G, Ince WL, Swanstrom R. Identification and recovery of minor HIV-1 variants using the heteroduplex tracking assay and biotinylated probes. Nucleic Acids Research. 36: e146. PMID 18948297 DOI: 10.1093/Nar/Gkn713  0.621
Show low-probability matches.